iRhythm Technologies, Inc.
IRTC
Updated: 25/09/2026, 10:31:40
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
No summaries found.
- Share price
- $110.80
- Market cap
- $3.64B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Quentin S. Blackford
- Employees
- 2,400
- IPO date
- 20/10/2016
- Beta
- 1.316
- Last dividend
- $0.00
- Day range
- $109.51 – $112.08
- 52-week range
- $100.85 – $212.00
- 1-day performance
- -0.85%
- 1-year performance
- 9.87%
- Current drawdown (1Y)
- -47.74%
- CIK
- 0001388658
- CUSIP
- 450056106
- ISIN
- US4500561067
- Created
- 07/12/2025, 04:46:31
- Last update
- 25/09/2026, 10:31:40
Track iRhythm Technologies, Inc. with an AI analyst
See which prediction-market events move IRTC, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains
MarketBeat • STOCK • 18/05/2026, 09:04:56
iRhythm Holdings, Inc. (IRTC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 13/05/2026, 17:00:44
Wall Street Analysts Predict a 57.21% Upside in IRHYTHM HLDGS (IRTC): Here's What You Should Know
Zacks Investment Research • STOCK • 05/05/2026, 12:55:43
IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised
Zacks Investment Research • STOCK • 04/05/2026, 15:10:33
iRhythm Holdings, Inc. (IRTC) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 01/05/2026, 03:11:33
New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy
GlobeNewsWire • STOCK • 27/04/2026, 10:05:00
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
PRNewsWire • STOCK • 09/04/2026, 11:49:00
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
Zacks Investment Research • STOCK • 01/04/2026, 14:41:22
iRhythm Technologies, Inc. (NASDAQ:IRTC) Sees Positive Outlook from William Blair
Market Data • Market Data • 20/02/2026, 20:03:53
iRhythm Holdings, Inc. (IRTC) Q4 Earnings and Revenues Beat Estimates
Zacks Investment Research • STOCK • 19/02/2026, 19:40:20
iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
GlobeNewsWire • STOCK • 05/02/2026, 17:30:00